The multifunctional iRGD-Trast functionalized liposomes, loaded with both GFB and LCH, are proposed to significantly enhance drug delivery efficiency into various solid tumors, particularly in targeting HER2-positive breast cancer brain metastases. This evidence concerns the gene ERBB2 and breast carcinoma.